0

    532039

    ZENOTECH

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    ZENOTECH LABORATORIES LTD. Share Price Today

    Investment Returns

    Over 1 Month 0.74% Over 3 Months 2.13% Over 6 Months -0.44% Over 1 Year -21.43%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    ZENOTECH LABORATORIES LTD. fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 271.30
    • P/E Ratio (TTM) -109.46
    • Beta 1.06
    • Book Value / share 15.58
    • Return on equity 1.66%
    • EPS (TTM) 0.00
    • Dividend yield [-]%
    • Net profit/quarter (Cr) -0.46
    info icon alternate text

    ZENOTECH LABORATORIES LTD. Financials

    Open financial information
    Revenue
    Net income
    Particulars JUN 2026 (Values in Cr)
    Revenue 9.60
    Operating Expense 11.65
    Net Profit -0.46
    Net Profit Margin (%) -4.79
    Earnings Per Share (EPS) -0.07
    EBITDA 1.29
    Effective Tax Rate (%) 25.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 8.87
    Operating Expense 11.47
    Net Profit -3.15
    Net Profit Margin (%) -35.51
    Earnings Per Share (EPS) -0.52
    EBITDA 0.82
    Effective Tax Rate (%) -236.17
    Particulars DEC 2025 (Values in Cr)
    Revenue 11.83
    Operating Expense 10.39
    Net Profit 1.93
    Net Profit Margin (%) 16.31
    Earnings Per Share (EPS) 0.32
    EBITDA 4.39
    Effective Tax Rate (%) 25.48
    Particulars SEP 2025 (Values in Cr)
    Revenue 10.23
    Operating Expense 10.73
    Net Profit -0.84
    Net Profit Margin (%) -8.21
    Earnings Per Share (EPS) -0.14
    EBITDA 3.04
    Effective Tax Rate (%) 165.87
    Particulars JUN 2025 (Values in Cr)
    Revenue 8.64
    Operating Expense 8.95
    Net Profit 0.99
    Net Profit Margin (%) 11.45
    Earnings Per Share (EPS) 0.16
    EBITDA 3.05
    Effective Tax Rate (%) 22.65
    Particulars MAR 2026 (Values in Cr)
    Revenue 39.56
    Operating Expense 41.54
    Net Profit -1.07
    Net Profit Margin (%) -2.70
    Earnings Per Share (EPS) -0.18
    EBITDA 11.30
    Effective Tax Rate (%) 125.53
    Particulars MAR 2025 (Values in Cr)
    Revenue 38.98
    Operating Expense 35.83
    Net Profit 5.61
    Net Profit Margin (%) 14.39
    Earnings Per Share (EPS) 0.92
    EBITDA 17.65
    Effective Tax Rate (%) 47.52
    Particulars MAR 2024 (Values in Cr)
    Revenue 36.76
    Operating Expense 30.70
    Net Profit 8.30
    Net Profit Margin (%) 22.57
    Earnings Per Share (EPS) 1.36
    EBITDA 18.23
    Effective Tax Rate (%) 25.49
    Particulars MAR 2023 (Values in Cr)
    Revenue 38.35
    Operating Expense 29.00
    Net Profit 11.59
    Net Profit Margin (%) 30.22
    Earnings Per Share (EPS) 1.90
    EBITDA 21.78
    Effective Tax Rate (%) 20.13
    Particulars MAR 2022 (Values in Cr)
    Revenue 32.49
    Operating Expense 27.29
    Net Profit 22.18
    Net Profit Margin (%) 68.26
    Earnings Per Share (EPS) 3.63
    EBITDA 18.09
    Effective Tax Rate (%) -123.93
    Particulars MAR 2010 (Values in Cr)
    Book Value / Share 28.01
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.13
    EBITDA Margin -105.78
    Particulars MAR 2009 (Values in Cr)
    Book Value / Share 31.55
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.15
    EBITDA Margin -198.17
    Particulars MAR 2008 (Values in Cr)
    Book Value / Share 36.79
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.30
    EBITDA Margin -89.96
    Particulars MAR 2007 (Values in Cr)
    Book Value / Share 18.80
    ROE % 3.92
    ROCE % 1.59
    Total Debt to Total Equity 0.77
    EBITDA Margin 22.66
    Particulars MAR 2006 (Values in Cr)
    Book Value / Share 13.61
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.97
    EBITDA Margin -18.41
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 15.75
    ROE % 1.66
    ROCE % 3.21
    Total Debt to Total Equity 0.00
    EBITDA Margin 36.54
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 14.84
    ROE % 3.07
    ROCE % 4.09
    Total Debt to Total Equity 0.00
    EBITDA Margin 44.65
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 13.48
    ROE % 4.28
    ROCE % 5.31
    Total Debt to Total Equity 0.04
    EBITDA Margin 51.37
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 11.57
    ROE % 13.91
    ROCE % 6.37
    Total Debt to Total Equity 0.22
    EBITDA Margin 49.47
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 7.93
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.43
    EBITDA Margin 30.24
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 26.70
    Total Assets 111.03
    Total Liabilities 111.03
    Total Equity 96.13
    Share Outstanding 6
    Price to Book Ratio 3.30
    Return on Assets (%) 5.05
    Return on Capital (%) 5.84
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 19.68
    Total Assets 106.20
    Total Liabilities 106.20
    Total Equity 90.54
    Share Outstanding 6
    Price to Book Ratio 3.98
    Return on Assets (%) 7.81
    Return on Capital (%) 9.17
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 11.14
    Total Assets 100.87
    Total Liabilities 100.87
    Total Equity 82.27
    Share Outstanding 6
    Price to Book Ratio 3.49
    Return on Assets (%) 11.48
    Return on Capital (%) 14.08
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 2.41
    Total Assets 94.08
    Total Liabilities 94.08
    Total Equity 70.64
    Share Outstanding 6
    Price to Book Ratio 4.35
    Return on Assets (%) 23.57
    Return on Capital (%) 28.94
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 2.45
    Total Assets 85.84
    Total Liabilities 85.84
    Total Equity 48.40
    Share Outstanding 6
    Price to Book Ratio 4.41
    Return on Assets (%) -1.41
    Return on Capital (%) -1.76
    Particulars MAR 2025 (Values in Cr)
    Net Income 10.69
    Cash from Operations 11.42
    Cash from Investing 15.28
    Cash from Financing 0.00
    Net change in Cash 24.77
    Free Cash Flow 15.29
    Particulars MAR 2024 (Values in Cr)
    Net Income 11.14
    Cash from Operations 12.89
    Cash from Investing -21.15
    Cash from Financing 0.00
    Net change in Cash -9.33
    Free Cash Flow 17.12
    Particulars MAR 2023 (Values in Cr)
    Net Income 14.50
    Cash from Operations 21.85
    Cash from Investing -5.82
    Cash from Financing -6.11
    Net change in Cash 8.72
    Free Cash Flow 28.08
    Particulars MAR 2022 (Values in Cr)
    Net Income 9.90
    Cash from Operations 18.67
    Cash from Investing -1.83
    Cash from Financing -15.87
    Net change in Cash -0.04
    Free Cash Flow 20.60
    Particulars MAR 2021 (Values in Cr)
    Net Income -1.21
    Cash from Operations 5.85
    Cash from Investing -4.81
    Cash from Financing 0.45
    Net change in Cash 1.37
    Free Cash Flow 10.76
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 34.87 14.47 1.68 267.22 23.12 38.85
    BLISS GVS PHARMA LTD. 467.40 37.63 4.16 4965.84 118.35 552.90
    CIPLA LTD 1472.95 33.25 3.45 118991.58 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 501.25 23.44 3.62 1475.23 256.40 507.20
    GLAXOSMITHKLINE PHARMACEUTICAL 2653.45 46.72 19.82 44951.04 2088.00 3202.80
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 34.87 24.38 4.49 267.22 23.12 38.85
    AMRUTAJAN HEALTH LTD 515.00 23.08 4.02 1488.90 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8103.65 105.90 23.21 20259.13 7630.00 9850.00
    BLISS GVS PHARMA LTD. 467.40 50.58 4.29 4965.84 118.35 552.90

    ZENOTECH LABORATORIES LTD. shareholding pattern

    Holding
    31.15%
    68.84%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    ZENOTECH LABORATORIES LTD. Technicals Summary

    44.45 -0.95 redarrow
    red-green-graph indicator
    15 Bearish
    1 Bullish
    • 5 Days 44.70
    • 26 Days 45.20
    • 10 Days 44.90
    • 50 Days 45.20
    • 12 Days 45.00
    • 100 Days 45.30
    • 20 Days 45.20
    • 200 Days 47.50
    44.60 PIVOT
    First Support 43.95 First Resistance 45.18 Second Support 43.37 Second Resistance 45.83 Third Support 42.72 Third Resistance 46.41
    RSI 46.20 ADX 11.06 MACD -0.19 Williams % R -75.22 Commodity Channel Index (CCI) -103.04
    Date 2026-07-31 Week 4004.00 Same Day 3404.00 Month 4977.00
    1 Year 1.07 3 Year 0.89
    Over 1 Month
    0.74% down
    Over 1 Year
    -21.43% down
    Over 3 Months
    2.13% down
    Over 3 Years
    -11.11% down
    Over 6 Months
    -0.44% down
    Over 5 Years
    -4.57% down

    ZENOTECH LABORATORIES LTD. Corporate Actions

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Zenotech Laboratories Ltd?

    Answer Field

    Zenotech Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 44.45 as on Aug 04 2026 12:42 PM.

    What is the Market Cap of Zenotech Laboratories Ltd Share?

    Answer Field

    The market cap of Zenotech Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 271.30 as on Aug 04 2026 12:42 PM.

    What is the 52 Week High and Low of Zenotech Laboratories Ltd?

    Answer Field

    The 52 Week High and Low of Zenotech Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 60.00 and ₹ 33.55.

    What is 1 year return for Zenotech Laboratories Ltd?

    Answer Field

    The 1 year returns on the stock has been -23.51%.

    What is the P/E Ratio of Zenotech Laboratories Ltd Share?

    Answer Field

    As on Aug 04 2026 12:42 PM the price-to-earnings (PE) ratio for Zenotech Laboratories Ltd share is -109.46.

    What is the PB ratio of Zenotech Laboratories Ltd Share?

    Answer Field

    As on Aug 04 2026 12:42 PM, the price-to-book (PB) ratio for Zenotech Laboratories Ltd share is 15.58.

    How to Buy Zenotech Laboratories Ltd Share?

    Answer Field

    You can trade in Zenotech Laboratories Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Zenotech Laboratories Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Zenotech Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Zenotech Laboratories Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |